Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.8K
Overview
85.8K
Immunological Memory01:23

Immunological Memory

17.7K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-12 mRNA-LNP promotes dermal resident memory CD4<sup>+</sup> T cell development.

NPJ vaccines·2025
Same author

An <i>Il12</i> mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses.

Science immunology·2025
Same author

Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β.

Cell reports·2025
Same author

A Quantitative Polymerase Chain Reaction (qPCR) Protocol Predictive of Treatment Outcome in Cutaneous Leishmaniasis Caused by <i>Leishmania braziliensis</i>.

Open forum infectious diseases·2025
Same author

What's the bug?: An unusual cause of bacterial meningitis in a patient with history of transsphenoidal surgery.

The American journal of emergency medicine·2025
Same author

Malnutrition disrupts adaptive immunity during visceral leishmaniasis by enhancing IL-10 production.

PLoS pathogens·2024

Related Experiment Video

Updated: Mar 16, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

16.7K

Memory T cells in cutaneous leishmaniasis.

Nelson D Glennie1, Phillip Scott1

  • 1Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Cellular Immunology
|August 6, 2016
PubMed
Summary

Leishmaniasis control relies on CD4+ Th1 cells. Long-lived central and skin resident memory T cells are key targets for a future leishmaniasis vaccine, offering sustained immunity without ongoing parasite presence.

Keywords:
LeishmaniaMemory T cellsVaccine

More Related Videos

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

11.1K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

16.7K
Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

11.1K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.5K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Leishmania parasites cause a range of diseases, from self-limiting to fatal.
  • Effective control requires CD4+ T helper 1 (Th1) cells producing interferon-gamma (IFNγ) to activate macrophages and eliminate intracellular parasites.
  • Current treatments for leishmaniasis can be toxic and ineffective, and no vaccine is available.

Purpose of the Study:

  • To investigate the role of different T cell populations in immunity to Leishmania infections.
  • To identify potential cellular targets for a future vaccine against leishmaniasis.
  • To understand the requirements for generating long-term protective immunity.

Main Methods:

  • The study focuses on the immunological response to Leishmania infection, particularly T cell populations.
  • Analysis of effector T cells, central memory T cells, and skin resident memory T cells following infection resolution.
  • Evaluation of the potential of these memory T cell populations to mediate secondary infection immunity.

Main Results:

  • Resolution of leishmaniasis leads to the generation of short-lived effector T cells and long-lived central memory T cells and skin resident memory T cells.
  • These long-lived memory T cells are capable of mediating immunity upon secondary infection.
  • A live infection induces immunity, but a vaccine needs to establish memory without persistent parasites.

Conclusions:

  • Long-lived memory T cells, specifically central memory and skin resident memory T cells, are crucial for sustained immunity to Leishmania.
  • These memory T cell populations represent promising targets for the development of a leishmaniasis vaccine.
  • Vaccine strategies should aim to generate and maintain these long-lived memory T cells for effective and lasting protection.